Circulating calprotectin as a biomarker of COVID-19 severity
M Mahler, PL Meroni, M Infantino… - Expert review of …, 2021 - Taylor & Francis
ABSTRACT Introduction Coronavirus disease 2019 (COVID-19) is an infectious disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …
Extracellular vesicle-based therapy for COVID-19: promises, challenges and future prospects
The COVID-19 pandemic has become a serious concern and has negatively impacted
public health and the economy. It primarily targets the lungs, causing acute respiratory …
public health and the economy. It primarily targets the lungs, causing acute respiratory …
Cytokines and microRNAs in SARS-CoV-2: What do we know?
FZ Rarani, B Rashidi, MHJN Abadi, MR Hamblin… - … Therapy-Nucleic Acids, 2022 - cell.com
The coronavirus disease 2019 (COVID-19) pandemic constitutes a global health
emergency. Currently, there are no completely effective therapeutic medications for the …
emergency. Currently, there are no completely effective therapeutic medications for the …
Prognostic markers in hospitalized COVID‐19 patients: the role of IP‐10 and C‐reactive protein
M Rizzi, M Costanzo, S Tonello, E Matino… - Disease …, 2022 - Wiley Online Library
Background. SARS‐CoV‐2 is responsible for COVID‐19, a clinically heterogeneous
disease, ranging from being completely asymptomatic to life‐threating manifestations. An …
disease, ranging from being completely asymptomatic to life‐threating manifestations. An …
[HTML][HTML] Potential treatment of COVID-19 with traditional Chinese medicine: what herbs can help win the battle with SARS-CoV-2?
L Li, Y Wu, J Wang, H Yan, J Lu, Y Wang, B Zhang… - Engineering, 2022 - Elsevier
Traditional Chinese medicine (TCM) has been successfully applied worldwide in the
treatment of coronavirus disease 2019 (COVID-19), which is caused by severe acute …
treatment of coronavirus disease 2019 (COVID-19), which is caused by severe acute …
The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN
The widespread occurrence of SARS-CoV-2 has had a profound effect on society and a
vaccine is currently being developed. Angiotensin-converting enzyme 2 (ACE2) is the …
vaccine is currently being developed. Angiotensin-converting enzyme 2 (ACE2) is the …
[HTML][HTML] N-acetylcysteine for prevention and treatment of COVID-19: current state of evidence and future directions
JL Izquierdo-Alonso, S Pérez-Rial, CG Rivera… - Journal of infection and …, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes
coronavirus disease 2019 (COVID-19) and can be associated with serious complications …
coronavirus disease 2019 (COVID-19) and can be associated with serious complications …
Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs
Abstract SARS-CoV-2, as the causative agent of COVID-19, is an enveloped positives-sense
single-stranded RNA virus that belongs to the Beta-CoVs sub-family. A sophisticated hyper …
single-stranded RNA virus that belongs to the Beta-CoVs sub-family. A sophisticated hyper …
How does SARS-CoV-2 affect the central nervous system? A working hypothesis
F Panariello, L Cellini, M Speciani, D De Ronchi… - Frontiers in …, 2020 - frontiersin.org
Interstitial pneumonia was the first manifestation to be recognized as caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, in just a few weeks, it …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, in just a few weeks, it …
Neutrophil–lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis
There is an ongoing need for accurate prognostic biomarkers in the milieu of acute ischemic
stroke (AIS) receiving reperfusion therapy. Neutrophil–lymphocyte ratio (NLR) has been …
stroke (AIS) receiving reperfusion therapy. Neutrophil–lymphocyte ratio (NLR) has been …